Last reviewed · How we verify
Dos of Afentanil 40 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Dos of Afentanil 40 (Dos of Afentanil 40) — Tongji Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dos of Afentanil 40 TARGET | Dos of Afentanil 40 | Tongji Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dos of Afentanil 40 CI watch — RSS
- Dos of Afentanil 40 CI watch — Atom
- Dos of Afentanil 40 CI watch — JSON
- Dos of Afentanil 40 alone — RSS
Cite this brief
Drug Landscape (2026). Dos of Afentanil 40 — Competitive Intelligence Brief. https://druglandscape.com/ci/dos-of-afentanil-40. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab